1. Home
  2. ELBM vs TENX Comparison

ELBM vs TENX Comparison

Compare ELBM & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELBM
  • TENX
  • Stock Information
  • Founded
  • ELBM 2011
  • TENX 1967
  • Country
  • ELBM Canada
  • TENX United States
  • Employees
  • ELBM N/A
  • TENX N/A
  • Industry
  • ELBM Industrial Machinery/Components
  • TENX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ELBM Miscellaneous
  • TENX Health Care
  • Exchange
  • ELBM Nasdaq
  • TENX Nasdaq
  • Market Cap
  • ELBM 22.8M
  • TENX 21.6M
  • IPO Year
  • ELBM N/A
  • TENX N/A
  • Fundamental
  • Price
  • ELBM $1.05
  • TENX $5.57
  • Analyst Decision
  • ELBM Strong Buy
  • TENX Strong Buy
  • Analyst Count
  • ELBM 1
  • TENX 3
  • Target Price
  • ELBM $2.40
  • TENX $16.00
  • AVG Volume (30 Days)
  • ELBM 129.0K
  • TENX 12.8K
  • Earning Date
  • ELBM 05-23-2025
  • TENX 05-20-2025
  • Dividend Yield
  • ELBM N/A
  • TENX N/A
  • EPS Growth
  • ELBM N/A
  • TENX N/A
  • EPS
  • ELBM N/A
  • TENX N/A
  • Revenue
  • ELBM N/A
  • TENX N/A
  • Revenue This Year
  • ELBM N/A
  • TENX N/A
  • Revenue Next Year
  • ELBM N/A
  • TENX N/A
  • P/E Ratio
  • ELBM N/A
  • TENX N/A
  • Revenue Growth
  • ELBM N/A
  • TENX N/A
  • 52 Week Low
  • ELBM $0.91
  • TENX $2.77
  • 52 Week High
  • ELBM $2.83
  • TENX $7.89
  • Technical
  • Relative Strength Index (RSI)
  • ELBM 41.14
  • TENX 46.68
  • Support Level
  • ELBM $1.05
  • TENX $5.49
  • Resistance Level
  • ELBM $1.14
  • TENX $5.87
  • Average True Range (ATR)
  • ELBM 0.05
  • TENX 0.34
  • MACD
  • ELBM 0.01
  • TENX 0.03
  • Stochastic Oscillator
  • ELBM 22.01
  • TENX 68.71

About ELBM Electra Battery Materials Corporation

Electra Battery Materials Corp is building North America's fully integrated, localized, and environmentally sustainable battery materials park. Electra Battery Materials is an integral part of the North American battery supply chain, providing low-carbon, sustainable, and traceable raw materials for the region's fast growing electric vehicle industry.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

Share on Social Networks: